Kevin Coleman
Vice President of Investor Relations and Treasurer
Replay available
AMETEK, Inc. (NYSE: AME) Q1 2025 earnings conference call, held 2025-05-01. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations and Treasurer
Chairman and Chief Executive Officer
Executive Vice President and Chief Financial Officer
Analyst, DA Davidson
Analyst, RBC Capital Markets
Analyst, Truist
Analyst, Vertical Research Partners
Analyst, Bank of America
Analyst, Mizzouho
Analyst, Seaport Research Partners
Analyst, Milius Research
Analyst, BNP Paribas
Hello, and welcome to the first quarter 2025 Amatek earnings conference call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand has been raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. It is now my pleasure to introduce Vice President of Investor Relations and Treasurer, Kevin Coleman. Thank you, Andrew. Good morning, and welcome to Amatek's first quarter 2025 earnings conference call. Joining me today are Dave Zipico, Chairman and Chief Executive Officer, and Dollar Puri, Executive Vice President and Chief Financial Officer. During the course of today's call, we'll be making forward-looking statements which represent the company's current expectations and are based on information currently available to the company. Various risk factors and uncertainties, including government trade policies and tariffs, could cause actual results to differ materially from our current expectations. A detailed discussion of the risk and uncertainties that may affect our future results is contained in AMETEC's filings with the SEC. AMETEC disclaims any intention or obligation to update or revise any forward-looking statements. Any references made on this call to 2024 or 2025 results or 2025 guidance will be on an adjusted basis, excluding after-tax acquisition-related intangible amortization and excluding a pre-tax $29.2 million or $0.10 per per diluted share charge in the first quarter of 2024 for integration costs related to the Paragon medical acquisition. Reconciliations between G...